Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123566202 | 12356620 | 2 | F | 201603 | 20160705 | 20160511 | 20160719 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-26900BP | BOEHRINGER INGELHEIM | 56.42 | YR | F | Y | 0.00000 | 20160719 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123566202 | 12356620 | 1 | PS | CATAPRES-TTS | CLONIDINE | 1 | Subcutaneous | 0.3571 MG | Y | 1309453 | 18891 | 2.5 | MG | /wk | |||||
| 123566202 | 12356620 | 2 | SS | CATAPRES-TTS | CLONIDINE | 1 | Subcutaneous | DOSE PER APPLICATION: 0.2M; FORMULATION: PATCH | Y | 1309453 | 18891 | /wk | |||||||
| 123566202 | 12356620 | 3 | SS | CATAPRES-TTS | CLONIDINE | 1 | Subcutaneous | DOSE PER APPLICATION: 0.3M; FORMULATION: PATCH | Y | 1309453 | 18891 | /wk | |||||||
| 123566202 | 12356620 | 4 | C | generic catapress | 2 | Unknown | 0 | ||||||||||||
| 123566202 | 12356620 | 5 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Unknown | 5 MG | 0 | 5 | MG | QD | |||||||
| 123566202 | 12356620 | 6 | C | Doxysozine | 2 | Unknown | 2 MG | 0 | 2 | MG | QD | ||||||||
| 123566202 | 12356620 | 7 | C | CLONIDINE. | CLONIDINE | 1 | Unknown | 0.1 MG | 0 | .1 | MG | QD | |||||||
| 123566202 | 12356620 | 8 | C | NUCYNTA | TAPENTADOL HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 123566202 | 12356620 | 9 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | 50 MCG | 0 | 50 | UG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123566202 | 12356620 | 1 | Hypertension |
| 123566202 | 12356620 | 4 | Product used for unknown indication |
| 123566202 | 12356620 | 5 | Product used for unknown indication |
| 123566202 | 12356620 | 6 | Product used for unknown indication |
| 123566202 | 12356620 | 7 | Product used for unknown indication |
| 123566202 | 12356620 | 8 | Product used for unknown indication |
| 123566202 | 12356620 | 9 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123566202 | 12356620 | Feeling abnormal | |
| 123566202 | 12356620 | Hypertension | |
| 123566202 | 12356620 | Product quality issue | |
| 123566202 | 12356620 | Skin irritation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123566202 | 12356620 | 1 | 2007 | 2010 | 0 | |
| 123566202 | 12356620 | 2 | 2010 | 2013 | 0 | |
| 123566202 | 12356620 | 3 | 2013 | 0 | ||
| 123566202 | 12356620 | 4 | 2014 | 2016 | 0 |